Here are four points:
1. A rise in degenerative disease cases will drive the market’s growth.
2. Lateral lumbar interbody fusion surgery complications will present an obstacle for the market’s growth.
3. The market will see regulatory changes in device classification.
4. DePuy Synthes, Medtronic, NuVasive and Stryker lead the market.
More articles on devices:
Australian researcher creates new spinal fusion device: 6 insights
LDR Holding partners with Poly-Shape for spinal implant manufacturing: 5 points
Global hip, knee orthopedic surgical robots market to reach $5B by 2022 — 4 things to know
